TCTMD

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

BOSTON, MA—(UPDATED) Patients with severe symptomatic degenerative mitral regurgitation (MR) ineligible for surgery fare just as well when treated with the Pascal device (Edwards Lifesciences) as ...
Hosted on MSN

Edwards Lifesciences’ PASCAL System: A Promising Trial in Heart Valve Repair

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. is currently conducting a pivotal clinical trial titled ‘Edwards PASCAL Transcatheter ...
TCTMD

Pascal TEER Device Performs Well in Patients With Complex Anatomy

BOSTON, MA—Patients with significant symptomatic degenerative mitral regurgitation (MR) who had complex anatomy making them ineligible for inclusion in the CLASP IID trial can be treated safely and ...
Nasdaq

Edwards Lifesciences (EW) Recalls PASCAL's Guide Sheath

Edwards Lifesciences Corporation EW is in the process of recalling a guide sheath used with its PASCAL transcatheter mitral valve repair system sold in Europe because of a possible damage to the ...
Seeking Alpha

CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION

SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...
Healio

Pascal noninferior to MitraClip for treatment of degenerative mitral regurgitation

Please provide your email address to receive an email when new articles are posted on . BOSTON — A novel mitral valve transcatheter edge-to-edge repair system was noninferior to an existing system in ...